The strategy of inhibiting ERK 1/2, AKT and STAT3 activity is extensively studied in various cancers, as these proteins are believed to be essential in overcoming the invasiveness and chemoresistance of cancer cells [12,14,24,45,52,53]. The gene discussed is AKT1; the disease is cancer.